Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.32 - $10.46 $155,472 - $257,316
24,600 Added 135.91%
42,700 $324,000
Q1 2024

May 15, 2024

BUY
$4.51 - $8.92 $34,727 - $68,684
7,700 Added 74.04%
18,100 $154,000
Q4 2023

Feb 14, 2024

SELL
$4.82 - $6.25 $12,050 - $15,625
-2,500 Reduced 19.38%
10,400 $58,000
Q3 2023

Nov 15, 2023

BUY
$4.32 - $5.77 $55,728 - $74,433
12,900 New
12,900 $67,000

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $508M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.